Comparative Evaluation of the Effect of Hepatoprotectors on Oxidative Homeostasis in the Blood of Patients with Alcoholic Hepatitis: A Randomized Experimental Study

Comparative Evaluation of the Effect of Hepatoprotectors on Oxidative Homeostasis in the Blood of Patients with Alcoholic Hepatitis: A Randomized Experimental Study

Background. An analysis of published results on the chemical structure, pharmacodynamics and pharmacokinetics of hepatoprotective agents, as well as their practical application, shows that a holistic view on the pharmacology of hepatoprotective agents is yet to be developed. Thus, the relationship b...

Full description

Bibliographic Details
Main Authors:	I. M. Bykov, G. A. Ermakova, K. A. Popov, I. Yu. Tsymbalyuk, M. I. Bykov, Ya. E. Denisova, S. M. Tutarisheva
Format:	Article
Language:	Russian
Published:	Ministry of Healthcare of the Russian Federation. “Kuban State Medical University” 2023-02-01
Series:	Кубанский научный медицинский вестник
Subjects:	alcoholic hepatitis hepatoprotectors ademethionine ursodeoxycholic acid succinic acid metabolic therapy oxidative stress antioxidants
Online Access:	https://ksma.elpub.ru/jour/article/view/3007

Similar Items

Alcoholic liver disease: State-of-the-art
by: I V Maev, et al.
Published: (2014-04-01)

Hepatoprotectors in the therapy of some hepatic diseases
by: O. N. Minushkin
Published: (2016-12-01)

Monitoring of the assortment structure and price dynamics of hepatoprotectors in the modern Ukrainian pharmaceutical market
by: I. O. Pukhalska, et al.
Published: (2020-11-01)

Alcohol-induced liver disease: primary and secondary prevention
by: S. V. Plyusnin, et al.
Published: (2024-03-01)

Evaluating the Efficiency of Hepatoprotector Hepa Veda in Patients with Liver Pathology
by: Yu.M. Stepanov, et al.
Published: (2015-04-01)

Efficiency of Combined Hepatoprotector Forceliv in the Treatment of Chronic Diffuse Liver Disease
by: Yu.M. Stepanov, et al.
Published: (2014-11-01)

Efficacy of ursodezoxycolic acid in the treatment of non-alcoholic fatty liver disease
by: D. T. Dicheva, et al.
Published: (2018-04-01)

Efecto hepatoprotector, antioxidante y anticancerígeno de la espirulina
by: Richard García-Ishimine, et al.
Published: (2020-11-01)

Drug-induced liver disease: role of hepatoprotectors
by: L. Y. Ilchenko, et al.
Published: (2013-12-01)

Гастропротекторная эффективность гепатопротекторов у крыс с токсическим гепатитом = Gastroprotective effects of hepatoprotectors in toxic hepatite rats
by: A. A. Petrenko, et al.
Published: (2016-06-01)

A case of idiopathic GGT elevation with acute hepatitis A
by: Jaspreet Singh, et al.
Published: (2019-01-01)

Efficacy of Putri Malu Leaf Plant (Mimosa Pudica Linn) as Hepatoprotectors on Ibuprofen Induced Hepatic Damage in White Mice (Mus Musculus)
by: Andre Bagaskara, et al.
Published: (2022-02-01)

May Ursodeoxycholic Acid Significantly Improve Liver Function Tests among Patients with Hepatitis C?
by: Alpaslan Tanoglu, et al.
Published: (2015-12-01)

Clinical Experience of Using Biological Hepatoprotector Prohepar in the Treatment of Patients with Hepatobiliary Pathology (Review)
by: Yu.M. Stepanov, et al.
Published: (2015-09-01)

The antidysbiotic and antiphlogistic actions of quertulin at the experimental toxic hepatitis
by: A. P. Levitsky, et al.
Published: (2017-03-01)

The antidysbiotic and antiphlogistic actions of quertulin at the experimental toxic hepatitis
by: A. P. Levitsky, et al.
Published: (2017-03-01)

Efecto antioxidante y hepatoprotector del Petroselinum sativum (perejil) en ratas, con intoxicación hepática inducida por paracetamol
by: Luzmila Troncoso, et al.
Published: (2007-12-01)

THE ROLE OF URSODEOXYCHOLIC ACID IN THE TREATMENT OF CHRONIC VIRAL HEPATITIS
by: R. G. MYAZIN
Published: (2017-05-01)

Rational choice of hepatoprotectors for drug-induced liver injury
by: H.V. Osyodlo, et al.
Published: (2022-09-01)

POSSIBILITY OF HELICOBACTER PYLORI ERADICATION THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C
by: Derbak M. A., et al.
Published: (2020-12-01)

Ursodeoxycholic Acid Regulates Hepatic Energy Homeostasis and White Adipose Tissue Macrophages Polarization in Leptin-Deficiency Obese Mice
by: Yu-Sheng Chen, et al.
Published: (2019-03-01)

Protective effects of ursodeoxycholic acid on ceftriaxone-induced hepatic injury in rats
by: Khaled A. Alhumaidha, et al.
Published: (2014-06-01)

Development of the inflammatory process and endogenic intoxication in colorectal cancer after the application of cytostatics and hepatoprotectors
by: L. E. Grytcishin, et al.
Published: (2020-10-01)

Protective Effects of Ursodeoxycholic Acid on Valproic Acid Induced Hepatotoxicity in Epileptic Children with Recurrent Seizure; A Double-Blinded Randomized Clinical Trial
by: Iraj Shahramian, et al.
Published: (2020-03-01)

Metabolic correctors based on siccine acid as pathogenic therapy in chronic virus hepatitis
by: Viktoriya Valer'evna Stel'makh, et al.
Published: (2011-02-01)

Efficiency of ademethionine in oxidative stress in tissues of irradiated rats
by: G. F. Stepanov, et al.
Published: (2021-06-01)

The clinical efficacy of a succinate-containing infusion drug during pharmacotherapy for hepatic lesions of varying genesis: results of meta-analysis
by: N K Mazina, et al.
Published: (2013-01-01)

Study of Hepatoprotective Effect of Silymarin and Ursodeoxycholic Acid in Chronic Hepatitis C Patients
by: Shahira Fawzy El Menshawe, et al.
Published: (2014-12-01)

The state of the cytokine profile in pregnant women with non-alcoholic fatty liver disease at the stage of non-alcoholic steatohepatitis with varying degrees of comorbid obesity under the influence of the developed complex therapy program
by: L. V. Bahnii, et al.
Published: (2023-04-01)

Evaluation of antifungal and antibacterial activities of monoesters of succinic anhydride
by: M. Iqbal,, et al.
Published: (2014-01-01)

Primary biliary cholangitis‐autoimmune hepatitis overlap syndrome: Case report and literature review
by: Chantelli Iamblaudiot Razafindrazoto, et al.
Published: (2021-03-01)

HEPATOPROTECTIVE ACTION OF BIOPREPARATIONS FROM DEFATTED SOY AND SUNFLOWER LECITHINS
by: Drozdov O. L., et al.
Published: (2014-02-01)

Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy
by: M V Maevskaya, et al.
Published: (2019-02-01)

Use of ursodeoxycholic acid in patients with hypertransaminasemia
by: Claudio Puoti, et al.
Published: (2014-09-01)

A high-dose of ursodeoxycholic acid treatment alleviates liver inflammation by remodeling gut microbiota and bile acid profile in a mouse model of non-alcoholic steatohepatitis
by: Hu Li, et al.
Published: (2024-05-01)

Optimization of therapy for hepatobiliary disorders in psoriatic patients
by: I V Kozlova, et al.
Published: (2017-12-01)

Experimental study of immunotropic properties of metabolites of <i>Bacillus subtilis B-9909</i> strain, promising in the formulation of a new hepatoprotector
by: N. А. Zabokritskiy
Published: (2023-06-01)

Non-alcoholic fatty liver disease associated with obesity: features ursodeoxycholic acid
by: D. I. Trukhan, et al.
Published: (2019-04-01)

The effect of complex pharmacotherapy regimens using a herbal remedy from <i>Hippophae rhamnoides</i> on biochemical blood parameters of rats with paracetamol hepatitis
by: S. Yu. Batueva, et al.
Published: (2024-01-01)

PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE AMONG OBESE PREGNANT WOMEN
by: I. O. Makarov, et al.
Published: (2016-09-01)